DGX
Quest DiagnosticsPrevious close
247.08
Change
0.00 / 0.00%
52-Week Range
171.18 – 248.65
P/E (TTM)
25.7
Forward P/E
20.1
Based on consensus earnings for the next 12 months
Market Cap
$27.3B
1M
+4.91%
S&P 500 −2.41% over same period
Volume / Avg Volume
948K / 989K
0.96× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-23 | $3.0B | 3.12 / 2.85 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-21 | $2.9B | 2.50 / 2.37 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-12 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-21 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-22 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-23 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 97 of its 5-year rangeExpensive
5-year range 17.4 – 24.6 · Median 21.3
Last 4 quarters: $450M in buybacks + $363M in dividends, 2.98% of market cap combined
P/E (TTM)
25.7
P/B
3.6
P/S
2.4
Dividend Yield
2.10%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.7% on average on the first trading day after, rising 2 times
Most recent −0.02%
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $8.3MNet selling $8.3M
- 09-01Davis J. E.CEO and PresidentSell$2.4M10,000 shares · Avg price 242.72
- 08-28PREVOZNIK MICHAEL ESVP & General CounselSell$5.5M22,677 shares · 3 trades · Avg price 243.11
- 07-28DELANEY MARK ESVP & Chief Commercial OfficerSell$0.38M1,600 shares · Avg price 235.18
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 3.04 | +10.2% | 33.7% | 0.32 | 2.84 |
| FY2026 Q1 | 2.90 | +9.2% | 32.5% | 0.25 | 2.24 |
| FY2025 Q4 | 2.81 | +7.1% | 32.4% | 0.25 | 2.18 |
| FY2025 Q3 | 2.82 | +13.2% | 33.7% | 0.25 | 2.16 |
| FY2025 Q2 | 2.76 | +15.2% | 34.2% | 0.28 | 2.47 |
| FY2025 Q1 | 2.65 | +12.1% | 32.5% | 0.22 | 1.94 |
| FY2024 Q4 | 2.62 | +14.6% | 32.7% | 0.22 | 1.95 |
| FY2024 Q3 | 2.49 | +8.4% | 32.6% | 0.23 | 1.99 |
| FY2024 Q2 | 2.40 | +2.5% | 33.5% | 0.23 | 2.03 |
| FY2024 Q1 | 2.37 | +1.5% | 32.6% | 0.19 | 1.72 |
| FY2023 Q4 | 2.29 | −1.9% | 32.2% | 0.19 | 1.70 |
| FY2023 Q3 | 2.30 | −7.7% | 32.9% | 0.23 | 1.96 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| DGX | 25.7 | +10.2% | 33.7% | +4.91% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |